Articles

This arrangement was approved by the shareholders at BELLUS on June 16, 2023, according to a company press release.

GSK Acquires BELLUS Health 

FDA approved Pfizer’s once-weekly human growth hormone analog for treatment of growth failure in pediatric patients.

FDA Approves Pfizer Human Growth Hormone Analog

The persistent poverty initiative aims to fight the cumulative effects of persistent poverty on cancer outcomes.

NCI Launches Persistent Poverty Initiative

Sobi has officially acquired CTI, a biopharma company focused on blood related cancers and rare diseases, in a merger valued at approximately $1.7 billion.

Sobi and CTI BioPharma Complete $1.7 Billion Acquisition Deal

The agency approved Elevidys to treat pediatric patients four through five years of age with Duchenne muscular dystrophy.

Gene Therapy for Duchenne Muscular Dystrophy Approved by FDA

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

The prestigious award, worth €20,000 (US$22,000), goes to Maurice Michel of the Science for Life Laboratory at Karolinska Institutet, Stockholm, Sweden. 

Maurice Michel of Sweden Wins 2023 Eppendorf Award for Young European Investigators

The companies hope address the need for efficient collection, cryopreservation, quality control, and logistics capabilities of leukapheresis materials to support various aspects of the cell therapy workflow.

SCTbio and Cyto-care Collaborate to Improve Cell Therapy Cryopreservation 

This collaboration is the first commercialization into the United States and Canadian markets for Rio Biopharmaceuticals.

Oliva Therapeutics to Partner with Rio Biopharmaceuticals 

The Segmentation by Exogenous Perfusion system uses a cell’s location in the tumor to find differences in gene activity.

NIH Develops Novel Tumor Identification Technology

FDA’s new draft guidance outlines key considerations for psychedelic drug development programs.

News